Phoma glomerata (Nelco Laboratories, Inc.)


Welcome to the PulseAid listing for the Phoma glomerata drug offered from Nelco Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nelco Laboratories, Inc.
NON-PROPRIETARY NAME: Phoma glomerata
SUBSTANCE NAME: PHOMA GLOMERATA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRADERMAL; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1972-08-29
END MARKETING DATE: 0000-00-00


Phoma glomerata HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPhoma glomerata from Nelco Laboratories, Inc.
LABELER NAME: Nelco Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10000([PNU]/mL)
START MARKETING DATE: 1972-08-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 36987-2055_42de87a6-4ad2-4dd1-ae19-915aec27f42c
PRODUCT NDC: 36987-2055
APPLICATION NUMBER: BLA102192

Other PHOMA GLOMERATA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Nelco Laboratories, Inc.Phoma glomerata